| [1] |
JIA Dongye, PAN Zhi.
Role of mitochondrial homeostasis in the pathogenesis of rheumatoid arthritis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(4): 541-547.
|
| [2] |
WANG Peipei, PAN Linkun, YANG Kui, FENG Dandan.
Qingluo Yin inhibits synovial angiogenesis induced by adjuvant in arthritis rats by regulating HIF-1α/VEGF pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(3): 366-373.
|
| [3] |
CAO Jun, ZHOU Yanlin, AI Zhengwen, LI Shigang.
Research progress on mechanism of action of Chaenomeles speciosa Nakai in the treatment of rheumatoid arthritis bone restruction
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(3): 404-411.
|
| [4] |
YANG Juanjuan, LI Haolin, YANG Tianning, CHENG Weigang, WANG Zhendong, JIN Fangmei, NIAN Fanghong, SU Xiaojun, WANG Jiaqiang, WANG Haiping, WANG Haidong.
Inhibition of Inflammation and Bone Destruction in mice with Collagen-induced Arthritis by Zushima Plaster
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(9): 979-987.
|
| [5] |
ZHANG Xiaoliang, GAO Saihong, YANG Yingchun, WANG Qingyu, JIA Shuyu.
Resveratrol activates autophagy and inhibits pyroptosis to alleviate cerebral ischemia-reperfusion injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(11): 1240-1248.
|
| [6] |
GUAN Rui, YAO Jiashu, ZHAO Yeyu, ZHENG Jiannan, QI Qing, YU Jing, GAO Mingli.
Analysis and verification of the effect of Yi Qi Yang Yin decoction on rheumatoid arthritis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(1): 26-36.
|
| [7] |
FAN Jie, JIN Yongming, JIANG Xiaolong, JIANG Guohua.
Molecular mechanism of lncRNA HOTAIR regulating miR-206 on the proliferation and apoptosis of rheumatoid arthritis synovial cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 736-742.
|
| [8] |
WANG Tiefeng, SU Jie, WANG Weidong, XIA Rongshuang, LI Sifan, ZHU Wenrui, LOU Zhaohuan.
Mechanisms of Radix Tetrastigma on anti rheumatoid arthritis via regulating the balance of Th17/Treg
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 138-146.
|
| [9] |
CAO Xuefen, LENG Yufang, HAN Xiaoxia, HOU Xiaoyu, LYU Xingjiao, Janvier NIBARUTA.
Tetramethylpyrazine protected against intestinal ischemia-reperfusion injury induced pyroptosis by inhibiting NLRP3 inflammasome activation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1201-1208.
|
| [10] |
YANG Zhian, ZHAO Yan, HE Yao, LIU Weiying, YU Qin.
Pyroptosis mediated renal injury caused by chronic intermittent hypoxia and the intervention effect of edaravone in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(1): 10-18.
|
| [11] |
PAN Shu, WU Yijin, ZHANG Sasa, WANG Qihai, LUO Tingting, YIN Qin.
Pharmacokinetics of methotrexate mediated by organic anion transporter 3 in adjuvant induced arthritis rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(5): 516-525.
|
| [12] |
CHEN Sen, FAN Chang, ZHANG Jiafu, MA Yanzhen, JIANG Hui.
The mechanism of Shugan Jianpi Formula regulating TLR4/MyD88/NLRP3 signaling axis to inhibit pyroptosis in mice with liver fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(10): 1081-1089.
|
| [13] |
LIU Xiaoling, SONG Zhenrong, FU Yuan, CHEN Min, SHI Ruizan, ZHANG Xuanping.
Ursolic acid alleviates the injury of human aortic endothelial cells induced by high glucose and high fat#br#
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(5): 522-531.
|
| [14] |
LU Yapeng, LIU Yang, HAO Wei, ZHONG Hailian, XIE Jianqin, LIU Jieting, WANG Yingbin.
Research progress on the role of pyroptosis in intestinal ischemia-reperfusion injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(12): 1437-1443.
|
| [15] |
SHENG Yongjia, LI Wenyan, ZHU Diwei, WANG Jin, GU Yanling.
Minocycline inhibits inflammatory corpuscle mediated pyroptosis and improves cognitive ability in Alzheimer's disease mice
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(6): 625-632.
|